Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03544333 · ClinicalTrials.gov registry record · NA
Boost rTMS for Auditory Verbal Hallucinations
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03544333 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 5 participants.
The verdict
NCT03544333, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a randomized, placebo controlled, double-blind clinical trial. The investigators aim to examine the safety and efficacy of repeated transcranial magnetic stimulation (rTMS) for the treatment of auditory verbal hallucinations (AVH) in patients with schizophrenia who are not taking antipsychotic medication. The investigators employ a novel, accelerated protocol with only four sessions of low-frequency rTMS in one day. The effects of this accelerated protocol will be compared to the sham stimulation. Additionally, the investigators will examine the effects of rTMS on a neurophysiological level by evaluating mechanism of action in the temporo-parietal lobe by means of functional magnetic resonance imaging.
Interventions
- DEVICE transcranial magnetic stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-04-16 |
| Est. Completion | 2019-01-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03544333
The ClinicalTrials.gov registry entry for NCT03544333 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which transcranial magnetic stimulation is the first listed.
NCT03544333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03544333 about?
NCT03544333 is a clinical study titled "Boost rTMS for Auditory Verbal Hallucinations". This is a randomized, placebo controlled, double-blind clinical trial. The investigators aim to examine the safety and efficacy of repeated transcranial magnetic stimulation (rTMS) for the treatment of auditory verbal hallucinations (AVH) in patients with schizophrenia who are not taking antipsychot...
What is the current status of trial NCT03544333?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2018-04-16. Estimated completion is 2019-01-22.
What interventions are being tested in trial NCT03544333?
The interventions under investigation include: transcranial magnetic stimulation (DEVICE).
Who is sponsoring clinical trial NCT03544333?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.